The American Committee for Disease Control and Prevention (CDC) and the American Immunization Advisory Committee (ACIP) recommend annual influenza vaccination for everyone aged 6 months and over to protect against the influenza virus. It is recommended that people with chronic diseases be vaccinated annually to protect themselves from serious complications of influenza.
Adult patients with chronic heart disease are 3 times more likely to be hospitalized due to influenza than patients without heart disease. In addition, serious complications such as influenza-related pneumonia, bronchitis, sinusitis and ear infections are more common in patients with chronic heart disease. Recent studies have found a relationship between heart attacks and acute respiratory infections that occur during peak influenza periods. There are studies showing that influenza virus infections can trigger cardiovascular occlusions and that the frequency of heart attacks increases during annual influenza periods. It has been determined that the risk of heart attack and stroke is 4 times higher after influenza-related respiratory tract infections, especially in the first 3 days.
A newly published meta-analysis has shown that heart attack triggered by influenza can be prevented by preventing influenza through vaccination. Therefore, the European Society of Cardiology (ESC) recommends annual influenza vaccination with a Class IIb recommendation level (it may be beneficial) for patients with cardiovascular occlusion. Again, the American Committee for Disease Control and Prevention (CDC) recommends pneumococcal vaccine for patients with chronic heart failure and cardiomyopathy (heart muscle diseases other than HT) between the ages of 19-64. It recommends additional pneumococcal vaccination for patients over the age of 65 with chronic heart failure, provided that 1 year has passed since the last vaccination.
The most appropriate time for influenza vaccination is the end of September and October.
>
Read: 0
